Application 215904

Type
NDA
Sponsor
MARINUS PHARMA INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001ZTALMYGANAXOLONESUSPENSION;ORAL50MG/MLNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
81583-100ZTALMYganaxoloneMarinus Pharmaceuticals, Inc.NDACurrent
81583-100ZTALMYganaxoloneMarinus Pharmaceuticals, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83845SUPPL 2025-10-21
83844SUPPL 2025-10-21
83843SUPPL 2025-10-21
83812SUPPL 2025-10-20
83811SUPPL 2025-10-20
83126SUPPL 2025-08-19
83060SUPPL 2025-08-07
74607SUPPL 2023-06-22
74605SUPPL 2023-06-22
74586SUPPL 2023-06-22
74585SUPPL 2023-06-22
72598SUPPL2022-11-10
72597SUPPL2022-11-10
72594SUPPL2022-11-10
72593SUPPL2022-11-10
72592SUPPL2022-11-10
71205ORIG2022-06-03
70751ORIG2022-04-12
70577ORIG2022-03-22
70738ORIG2022-03-18
70737ORIG2022-03-18
70558ORIG2022-03-18